Whole Slide Imaging Market Size, Share, Growth Analysis, By Technology(Scanners, IT Infrastructure, Viewer, Image Management System), By Application(Telepathology, Cytopathology, Immunohistochemistry, Hematopathology), By End User(Hospitals & Clinics, Pathology Laboratories, Academic & Research Institute, Others), By Region - Industry Forecast 2024-2031

North America is projected to hold the highest market share in the global whole slide imaging market during the forecast period. This dominance is driven by the increasing incidence of cancer and the growing adoption of digital pathology to enhance laboratory efficiency in the region. Notably, the American Cancer Society estimates around 1.9 million new cancer cases and 609,360 cancer-related deaths in the United States in 2022. The rising cancer burden is expected to lead to a surge in the demand for diagnostic laboratories and consequently accelerate market expansion in North America.

Similarly, Asia Pacific is poised for robust growth in the whole slide imaging market due to its expanding population base vulnerable to various diseases and a rise in drug discovery activities, particularly in India. For instance, in August 2020, the Indian Government announced plans to promote indigenous drug discovery and establish a dedicated research and development (R&D) cell to oversee these efforts. With over 3,000 pharmaceutical companies and more than 10,500 manufacturing facilities, India is a significant player in the pharmaceutical industry. Moreover, India ranks as the third-largest seller of medicines globally, indicating a substantial potential for whole slide imaging adoption in drug development and research activities in the region.